France’s Zyn Ban: A Cautionary Tale of European Nanny-State Overreach for American Policymakers
As someone who values individual liberty and evidence-based policy, I often watch Europe’s regulatory follies with a mix of amusement and alarm. France’s comprehensive ban on nicotine pouches like Zyn, which took effect in April, stands as a prime example of blind government overreach. Under this new law, the country prohibits not just the sale but the import, possession, offer, transfer, acquisition, and use (yes, that’s literally in the text) of non-medicinal oral nicotine products. Violators face up to five years in prison and fines reaching €375,000 for serious offenses, with personal possession punishable by up to one year in jail and a €15,000 fine.
This isn’t nuanced public health regulation like they want you to believe. It targets a relatively low-risk product while leaving more dangerous alternatives untouched. And at the end of the day, this is the same paternalistic prohibition masquerading as compassion that has become so synonymous with the American left - which is why it troubles me.
France justifies the crackdown primarily by citing the products’ appeal to young people. Discreet use, flavors, and rising nicotine poisoning cases - 131 cases in 2022, up from only 19 in 2020. Fair concerns on the surface, indeed, yet the same logic collapses under scrutiny. Cigarettes, for example, are responsible for vastly more disease and death, yet remain fully legal for adults in France, complete with their iconic branding, social ritual, and chain-smoking cafe culture. Flavored vapes, which saw explosive usage among youth globally, also escape this total ban. Why criminalize the cleaner, tobacco-free alternative while tolerating the combustion-driven killer?
The selective outrage reveals a discomfort with modern, innovative nicotine products that disrupt traditional tobacco markets.
The hypocrisy becomes glaring when you compare France to Sweden. Sweden has embraced harm reduction with snus and nicotine pouches, achieving Europe’s lowest smoking rate at around 5.3% and possibly even lower. France’s rate hovers near 25%, with daily smoking around 17-18% even after recent declines. Sweden’s pragmatic approach of treating adult nicotine use as a far safer alternative to smoking has driven massive reductions in tobacco-related disease. France’s prohibitionist stance will only deliver stagnation.
Data best underscores the missed opportunity. Nicotine pouches are tobacco-free, produce no smoke or tar, and rank significantly lower on harm scales than cigarettes. Banning nicotine pouches risks pushing users back to traditional tobacco products rather than facilitating switches. Sweden’s success isn’t theoretical; it’s a real-world demonstration that harm reduction works when governments prioritize outcomes over ideology.
From an American vantage point, this matters deeply. Too often, progressive American policymakers draw inspiration from European models - importing expansive government control under the banner of public good. They’ve done the same with “clean energy” policy for years. Democrats are once again signaling that instinct, like in New York, for example, where Governor Kathy Hochul has proposed slapping a 75% excise tax on nicotine products like Zyn. It would treat nicotine pouches the same as traditional tobacco products despite their lower risk profile. And some American policymakers are already pushing to ban flavored pouches, even as the U.S. Food and Drug Administration begins authorizing certain products for their potential to help smokers quit. Flavored vapes, too, faced aggressive restrictions several years earlier.
This pattern, alarmingly, echoes France: target the new, discreet alternatives while legacy products - and more importantly, their associated tax revenues - get a pass. It’s not consistent risk management. It’s cultural and political discomfort with consumer choice and personal agency.
The irony is glaring: France bans nicotine pouches to “protect public health,” while celebrating the chain-smoking cafes, wine at lunch, and steady diet of espressos that partly defines their culture. It highlights how bureaucrats have shifted from building strong societies to confiscating “contraband” from grown adults. It runs a slippery slope: today, Zyns, tomorrow red meat. The more pointed critique, however, is this: the left obsesses over control disguised as compassion, regulating every ounce of fun, risk, and personal responsibility out of existence. They will ignore the dangers of seed oils, ultra-processed foods, SSRIs, and late-night doomscrolling.
Young adults are noticing. This micromanagement of being taxed to death and lectured on vices and masculine habits is fueling a drift toward freedom-minded politics. It’s part of the reason why Donald Trump was the victor in 2024. Adults tire of being treated as permanent children needing permission slips from mommy-daddy bureaucrats. A healthy society produces resilient individuals capable of making informed choices, not dependents awaiting regulatory approval.
America must reject this path. Our nation’s governing documents prioritize liberty alongside safety. The U.S. Food and Drug Administration’s evolving stance on authorized products reflects a more balanced - even if imperfect - approach. The bottom line is this: we cannot import more of Europe’s failures.
American policymakers on the left who are thinking about restricting nicotine pouches would do well to study Sweden’s results rather than France’s rhetoric. True public health advances through innovation and choice, not prohibitionist reflexes. Overreach like France’s Zyn ban doesn’t protect the vulnerable - it erodes the freedoms that make self-governance possible.
In the states, we must champion better: evidence over emotion, and liberty over control.
Peter Giunta is a millennial voter and Republican strategist based in New York. He has appeared on Fox News and writes about the issues driving Republican voters from the youth perspective.